Structural specialization of the postsynaptic skeletal muscle membrane is in part mediated by the motor neuron-induced transcriptional regulation of synaptic muscle nuclei. ARIA, a factor that stimulates production of acetylcholine receptors (AChRs), is a candidate signaling molecule for such regulation. Here we examine the transynaptic inducing potential of this polypeptide factor. ARIA immunoreactivity is detectable at synaptic sites in vivo. In vitro, recombinant heregulin pl (rHRGpl), the human homolog of ARIA, induces expression of the AChR e gene, the subunit most sensitive to synaptic input. The inducing property of rHRGpl is demonstrated most dramatically in primary muscle cultures from transgenic mice bearing an ~ promoter-nuclear lacZ reporter transgene. Transient transfection experiments using the Sol 8 muscle cell line indicate that sequences that confer responsiveness to ARIA are located within a 150 bp z subunit promoter region and are E box-independent. These results suggest that ARIA performs a vital role by directing spatially restricted gene expression at the neuromuscular junction.
Introduction
Mutual and complementary inductive interactions between the motor neuron and its target muscle fiber are central to the development of the neuromuscular synapse. Many proteins that facilitate synaptic transmission appear as a result of this interaction. One distinguishing feature of this model synapse is the extraordinarily dense, nerve-dependent accumulation of acetylcholine receptors (AChRs). Found at densities of less than 10 per square micron extrasynaptically, AChRs are present at concentrations of greater than 10,000 per square micron in the postsynaptic membrane (Salpeter and Harris, 1983; Salpeter et al., 1988) . The postsynaptic accumulation of AChRs during neuromuscular development is mediated in large part by transcriptional regulation (for a review, see Hall and Sanes, 1993) . Initially, AChR genes are activated independently of the nerve, as part of the myogenic program of differentiation. After innervation, expression of the muscle-specific AChR subunit genes in addition are regulated bytwo nerve-dependent processes: first, nerve-induced electrical activity down-regulates AChR gene expression throughout the myofiber; second, the motor neuron exerts a positive influence on the muscle nuclei lying beneath the synapse, resulting in the localized induction of AChR subunit genes in a small subset of synaptic nuclei within the multinucleate muscle fiber.
Evidence that synaptic nuclei are transcriptionally distinct from extrasynaptic muscle nuclei initially came from comparisons of AChR subunit mRNA abundance in synapse-rich versus synapse-poor regions (Merlie and Sanes, 1985) . The finding that the synaptic region of the muscle fiber possesses enriched levels of AChR subunit mRNA, along with higher resolution observations using in situ hybridization and transgenic analyses indicating that AChR subunit genes are selectively expressed by muscle nuclei lying beneath the synapse, suggests that the motor neuron supplies a spatially restricted, transynaptic signal that results in the activation of specific genes needed for the development of the synaptic apparatus (Fontaine et al., 1988; Goldman and Staple, 1989; Brenner et al., 1990; Klarsfeld et al., 1991; Sanes et al., 1991; Simon et al., 1992) . Regulation of the AChR ~ subunit gene provides particularly good evidence for transynaptic induction of gene expression. The ~ gene exhibits strict spatial regulation; whereas the AChR a, 13, y, and 8 subunit genes are also regulated by mechanisms that permit expression outside the synaptic region under certain conditions, high levels of ~ gene expression occur only at the synapse. The ~ gene exhibits temporal regulation as well: during postnatal maturation of the synapse, embryonic, y subunit-containing AChRs (stoichiometry a213yS) are replaced by ~ subunit-containing receptors ((~2~s5; Mishina et al., 1986; Gu and Hall, 1988) . This postnatal switch mirrors the time course of ~ gene expression (Witzemann et al., 1989; . Studies involving transgenic mice demonstrate that the properties of both temporal and synapse-specific gene regulation are conferred by sequences within the ~ subunit promoter. The nlacZ reporter gene, which directs expression of an Escherichia coli l~-galactosidase targeted to nuclei when placed under control of ~ regulatory sequences (transgene ~-nlacZ), confers postnatal expression of the transgene in muscle nuclei directly beneath the motor endplate (Sanes et al., 1991; Gundersen et al., 1993) . Owing to its sensitivity to the presence of the motor neuron, the ~ subunit gene is an ideal gene to study synapse-specific gene regulation.
AChR-inducing activity (ARIA) is currently a leadingcandidate to be a motor neuron-derived inducer of AChR expression. This factor was initially characterized as an activity present in chicken brain and spinal cord extracts capable of increasing the rate of AChR synthesis in myotube cultures. Purification of this activity subsequently defined a 42 kDa glycoprotein (Usdin and Fischbach, 1986) . ARIA was shown to stimulate the expression of several AChR subunit genes, accounting for the observed increase in AChR synthesis . The ~ subunit exhibited the most dramatic effect: in mouse myotube cultures treated with ARIA, a subunit mRNA levels were induced 7-to 10-fold . The cloning of the gene encoding ARIA revealed it to be the chicken homolog of a mammalian gene encoding a family of proteins: neu differentiation factor (NDF), heregulin (HRG), and the Schwann cell mitogen glial growth factor, all derived from a single gene (Holmes et aL, 1992; Wen et al., 1992; Falls et al., 1993; Marchionni et al., 1993) . NDF and HRG were initially characterized by their ability tct bind and stimulate the neu (erbB2 and HER2) receptor tyrosine kinase, and were subsequently shown to interact with erbB3 and erbB4 (HER3 and HER4, respectively), additional members of the epidermal growth factor (EGF) receptor family of tyrosine kinases (Plowman et al., 1993b; Carraway et al., 1994; Kita et al., 1994; Sliwkowski et al., 1994; Tzahar et al., 1994) . The gene encoding ARIA exhibits a large degree of alternate splicing, resulting in great heterogeneity of predicted translation products. The name neuregulin has been proposed to encompass the gene and the diversity of ligands that it encodes (for review, see Benbaruch and Yarden, 1994) . ARIA belongs to the 151 subclass of neuregulins.
Here, in support of the hypothesis that ARIA is a physiologically important mediator of AChR regulation atthe neuromuscular junction, we first demonstrate that ARIA protein is present at the motor endplate. To investigate the inducing potential of ARIA, we examine the regulation of the AChR ~ subunit gene using a recombinant form of HRG, the human homolog of ARIA. In addition to activating the endogenous s subunit gene, this recombinant 68 amino acid peptide can exert an inductive effect on the subunit promoter: s-nlacZ, a synaptically expressed transgene in vivo, is essentially inactive in aneural cell culture from transgenic mouse muscle, yet in the presence of HRG, this transgene exhibits high levels of expression. We find a concordance between DNA sequences conferring synapse-specific expression in vivo and HRG-specific inducibility of the ~ subunit gene in vitro. Transient transfection experiments performed in a HRG-responsive cell line demonstrate that sequence elements sufficient for HRG-dependent signaling are located within 150 bp of the subunit transcription start site. Furthermore, cis-acting sequences that respond to HRG are separate from E box elements, a binding site for transcription factors involved in myogenic and activity-dependent gene regulation. In demonstrating the inductive potential of recombinant HRG/ARIA on the ~ subunit promoter in muscle cell culture, we reconstitute one major component of synaptic signaling in vitro, and thus provide a model for studying transynaptic gene regulation.
Results

Detection of ARIA at Synaptic Sites
To provide evidence for the motor neuron-dependent regulation of synapse-specific genes by ARIA, we wished to determine whether this factor could indeed be found at the neuromuscular junction. A polyclonal antibody raised against recombinant HRGI~I was used to stain cross sections of adult skeletal muscle, These sections were doubly stained with rhodamine-labeled ~-bungarotoxin to detect synaptic sites. ARiA-positive regions were found to coincide with motor endplates (Figure 1) . A bacterially expressed peptide corresponding to amino acids 177-244 of recombinant HRGI~I (rHRGI~I~_~) was used to affinity purify antibodies directed against this region. When antibody prepared in this manner was used to stain muscle sections, similar endplate-specific staining was observed (data not shown). Synaptic staining was not observed when nonimmune serum was used to stain similar sections (Figure lc) . Our finding that HRG/ARIA is concentrated at the synaptic region of the neuromuscular junction fulfills one requirement of a putative transynaptic inducing factor and is consistent with the inferred role of HRG/ARIA in stimulating synapse-specific gene transcription.
Recombinant HRGJ~I Stimulates Expression of the AChR ~ Subunit Gene
Sequences corresponding to the bioactive EGF-like domain of H RGI31 (rH RGI~ 117~-2~) were expressed and pu rifled from E. coil (Holmes et al., 1992) . To determine whether rHRGJ311~7_2~ possessed ARIA activity, we assayed ~ subunit mRNA levels in mouse primary muscle culture using an RNase protection assay. This analysis employed a genomic DNA fragment containing exons 2-4 of the ~ subunit gene for use as a riboprobe template. In the absence of any exogenous factors, the abundance of ~ subunit mRNA was very low, as observed previously in aneural muscle cultures . The addition of rHRGI~1~77_2~ to these cultures for 48 hr resulted in an approximately 9-fold induction of the ~ subunit gene (Figure 2A ). In contrast, rHRGI3117~_244-treated cultures caused only a slight increase (1.3-fold) in the expression of the "house-keeping" gene elongation factor eEF1 ( Figure 2B ). No stimulation of the ~ gene was observed when EGF, a structural analog of rHRG[~117~_244, was added to the cultures instead. These results show that recombinant HRGI~I possesses the AChR c subunit-stimulating activity that had previously been found in native In some experiments, the abundance of ~ subunit mRNA in unstimulated cultures was too low for accurate measurement; thus, the magnitude of HRG-dependent stimulation could not be determined. In cultures in which quantitation was possible, an 8.9-fold average stimulation was found.
(B) RNase protection of the eEFI~ gene. A probe synthesized from a cDNA clone was used to measure mRNA levels in 5 I~g of total RNA. Average stimulation was found to be 1.3-fold.
ARIA preparations, and that this induction demonstrates specificity in both the inducing factor as well as the genes that are activated.
In Vitro Activation of a Synapse-Specific Transgene
The ~3500nlacZ transgene (3.5 kb of the ~ subunit promoter fused to nlacZ) exhibits spatially restricted expression in muscle nuclei beneath the motor endplate (Sanes et al., 1991) . Expression of this transgene in vivo is thus an excellent indicator of synaptic input. We took advantage of this property by developing an in vitro assay for the induction of synapse-specific gene expression. Muscle cells from transgenic mice (line ~29) were dissociated and cultured. In this procedure, only the mononucleate satellite cells are mitotically active and proliferate in culture. These cells fuse and differentiate upon reaching confluence and when the serum-rich media is replaced with serum-poor media. Myotubes from ~3500nlacZ muscle cultured in this manner exhibited little expression of the transgene, with only an occasional nucleus showing any sign of I~-galactosidase accumulation ( Figure 3a ). This result was anticipated, for in the absence of neuronal innervation, the subunit gene is not expressed at high levels. Muscle cultures treated with rHRGI311n_2,~ for 72 hr exhibited a dramatic induction of transgene expression (Figures 3b and 3d) . Though some myotubes showed no transgene activation, intense nlacZ staining was observed in nuclei within many myotubes. In a small number of myotubes, a graded pattern of staining was present, which could be due to expression in a subset of nuclei within a given myotube with limited cytoplasmic diffusion of nlacZ mRNA or protein (Ralston and Hall, 1989) . Staining was not seen in either mononucleated, unfused myoblasts or the non-muscle cells that were present in these cultures. Although the majority of cell culture experiments were performed with cultures from line s29, the activation of the s3500nlacZ transgene was also observed in muscle cultures from line ~51, an independent transgenic mouse line possessing the ~3500nlacZ construct (data not shown). In a quantitative solution assay of I~-galactosidase activity, transgene expression in untreated cultures was slight. Activation was readily detected at 100 pM rHRGI31177_2,~ and was found to increase over two orders of magnitude of concentration ( Figure 4 ). The range of concentrations used in our assay is similar to those required to maximally phosphorylate p185 erbe2, one of the receptor targets of HRG activation (Holmes et al., 1992) . We thus find that rHRGI~I~7_2,~ can induce the in vitro expression of a transgene that in vivo exhibits strict synapse-specific regulation. This activation in culture occurs at a frequency far greater than that observed in innervated muscle, and is consistent with the hypothesis that availability of the specific nerve-derived signal (i.e., HRG/ARIA) is a limiting factor for ~ subunit expression in vivo.
To demonstrate the specificity of this effect, we assessed the ability of a series of other compounds to activate the a3500nlacZ transgene. Table 1 summarizes these results. EGF, a structural homolog of rHRGI~1177_244, failed to result in activation (Figure 3c ), as did ligands for a variety of other receptor tyrosine kinases. A recombinant preparation of agrin (Ferns et al., 1993) , which has been shown to induce the posttranslational clustering of AChR, did not result in stimulation of the transgene. Finally, calcitonin gene-related peptide and ascorbic acid, two compounds that have been shown to increase AChR (z subunit mRNA in myotube cultures (Fontaine et al., 1987; Horovitz et al., 1989) , also failed to induce the expression of nlacZpositive nuclei. Thus, of the compounds analyzed, only rHRGI}1177_=,~ was found to be capable of substituting for the effects of the motor neuron in culture.
The results obtained above indicate that sequences within 3500 bp of the ~ subunit transcriptional start site confer HRG inducibility. Recently, ~280nlacZ, a construct bearing only 280 bp of regulatory sequences fused to the nlacZ reporter, was also shown to direct synapse-specific staining when expressed in transgenic mice (Gundersen et al., 1993) . When muscle cultures were prepared from ~280nlacZ mice, myotubes treated with rHRGI~ll~-z,~ exhibited activation of this transgene. As found for the penetrance of expression of this transgene in vivo, the degree of expression of ~280nlacZ in culture was weaker . Dose-Dependent Effect of rHRG~1177-2,.4on the ~3500nlacZ Transgene Primary muscle cultures were prepared from transgenic mice or wildtype controls from the same genetic background. ~-Galactosidase activity was quantified on day 7, after a 3 day treatment with varying concentrations of rHRGI~1~T7_2~4 using an ONPG solution assay. Activity is defined as A420 per milligram of protein per hour assayed. Nontransgenic controls were assayed in parallel to assess the endogenous I~-galactosidase contribution to the total enzymatic activity. Each point on the transgenic data curve represents the average of 7 wells from two independent experiments; controls were performed in quadruplicate. Error bars indicate SEM.
than that of s3500nlacZ. To quantitate the effects of rHRGI~I ~77-244 on ~280nlacZ cultures, myotubes were visually scored for activation of the transgene. A myotube was considered positive if a single nucleus within the myotube exhibited 13-galactosidase activity. Despite the lower levels of expression, the s280nlacZ construct exhibited an inductive response to rHRGI31177-244 similar to that of the ~3500nlacZ transgene ( Figure 5 ). These results suggest that the ability of the ~ subunit gene to respond to HRG, like its ability to respond to the motor neuron, is mediated by regulatory elements in the ~ subunit promoter.
Analysis of HRG/ARIA-Dependent Gene Regulation in a Muscle Cell Line
For further analysis of the ARIA-mediated induction of gene expression, we turned to Sol 8, a fusion-competent muscle cell line derived from the mouse soleus muscle (Mulle et al., 1988) . Sol 8 cells possess the ability to express increased (albeit low) levels of s subu nit: m RNA when maintained for extended periods of time in culture and can generate functional adult AChRs (Pinset et al., 1991) . We found that, in the absence of rHRGI31177-244, Sol 8 cells did indeed exhibit extremely low levels of E subunit mRNA ( Figure 6A ). However, Sol 8 myotube cultures treated with rHRGI~1177-244 exhibited on average a 12.6-fold induction of the s subunit gene. The eEFI~ gene showed no change in response to similar treatment (0.98; n = 4; see Figure  6B ). We sought to take advantage of the availability of this easily manipulated cell line to characterize further the cisacting region of the s subunit promoter that confers HRG inducibility. Plasmid constructs bearing s promoter sequences fused to the bacterial reporter chloramphenicol acetyltransferase (CAT) were transiently transfected into Sol 8 cultures, rHRGI31177-244 was added to the cultures 24 hr after induction of differentiation by transfer to low-serum media. The CAT reporter gene was used in place of the nlacZ reporter to facilitate quantitation and comparison with other promoter-CAT constructs. Construct s280-CAT, containing regulatory sequences identical to those present in the s280nlacZ transgenic mouse, exhibited a 4-fold stimulation in expression when the cultures were treated with rH RGI31177-244. A shorter construct, s150-CAT, demonstrated a similar, 6-fold effect (Figure 7) . In contrast, a plasmid containing sequences from the human cardiac alpha actin gene fused to CAT showed no induction in response to rHRG~1177_244 (Figure 7) . The magnitude of induction on the ~ subunit promoter seen in these transient assays (4-to 6-fold) was found to be somewhat less than that observed for endogenous s subunit mRNA (9-to 12-fold), or for induction of the nlacZ reporter gene in transgenic mice. We suggest that transiently transfected plasmid constructs exhibit higher levels of basal (unstimulated) expression as compared with the uninduced expression levels observed in genes that have been stably integrated into chromosomal DNA (as is the case for the endogenous s subunit gene and the s-nlacZ transgene). This effect in transient transfection may therefore result in an apparent HRG-dependent induction which is somewhat less robust than that observed with integrated genes. Nonetheless, these transfection experiments indicate that the proximal 150 bp of promoter sequence can confer HRG responsiveness to the s subunit gene, and as a result establish a cell culture system whereby mechanisms of HRG-dependent (and perhaps synapse-specific) gene regulation may be elucidated.
E Box-Independent Mediation of the Heregulin Response
The E box element, defined by the consensus sequence CANNTG, is the target binding site for the family of myogenic basic-helix-loop-helix transcription factors MyoD, myogenin, MRF4, and myf5. E boxes are present in the regulatory regions of all the AChR subunit genes and are involved in activation of these genes during the myogenic differentiation program (Piette et al., 1990; Prody and Merlie, 1992; Simon and Burden, 1993) . Electrical activitydependent AChR subunit gene regulation by an E box element has also been shown for the AChR a and 8 subunit genes (Bessereau et al., 1994; Tang et al., 1994) . The subunit gene contains two E boxes within 280 bp of the transcriptional start site, but deletion analysis indicates the distal E box is unnecessary for cell type-and differentiation-specific expression (Duclert et al., 1993; Sunyer and Merlie, 1993) . To determine whether E box sequences are involved in mediating HRG-dependent signaling, construct ~150(mutE)-CAT was transfected into Sol 8 cells. This plasmid contains a mutation in the remaining, proximal E box. In the absence of exogenously added rHRG~11~_244, the uninduced level of expression of ~150(m utE)-CAT was found to be approximately one-tenth that of the unmutated construct (Figure 7 ). However, this mutation did not abolish the HRG-induced effect. Although the absolute level of induced expression was also reduced in this mutant construct, the HRG-dependent magnitude of induction was found to be 14-fold, greater than the 6-fold induction observed with the wild-type ~150-CAT plasmid. The E box may therefore regulate levels of myogenic factor-dependent expression, but it is unlikely to be involved directly in HRG-induced gene expression.
Discussion
Activation of the AChR ~ Subunit Gene by Recombinant HRG/ARIA Transgenic and in situ hybridization studies have previously suggested that the motor neuron supplies a signal which induces the synaptic expression of the AChR ~ subunit gene. In agreement with these observations, we find that, in muscle cells cultured in the absence of innervation, low levels of endogenous ~ subunit mRNA or reporter gene activity from ~-nlacZ transgenic mice can be detected. Of the many compounds tested, only HRG can substitute for the synaptic signal by inducing the ~ subunit gene in myotube cultures. Furthermore, we find a correlation between promoter sequences involved in synapse-specific gene expression in vivo and HRG-induced gene expression in vitro. These results, along with our finding that HRG is localized at neuromuscular synapses, strongly suggest that HRG/ARIA is a physiologically important mediator of the motor neu ron-dependent regulation of synaptically expressed muscle genes. In examining the relationship between HRG and ~ gene expression, we have established an in vitro model that may be used to study mechanisms of transynaptic induction of gene expression. The cell culture model demonstrates the following properties: first, recombinant HRG stimulates endogenous mRNA levels of the AChR ~ subunit gene, a synapse-specific gene. Second, ~ promoter sequences that direct the in vivo synaptic expressien of a nlacZ reporter in transgenic mice also respond to induction by HRG in primary muscle culture. Third, in transient transfection of a muscle cell line, HRG can increase expression of a CAT reporter construct when placed under the control of the ~ proximal promoter. This model may be used to understand various processes necessary for synapsespecific gene expression, i.e., defining synaptic cis-acting sequences and trans-acting DNA binding proteins and elucidating signaling intermediates.
We used a recombinant fragment of HRGI31, the human homolog of ARIA, as our source of this inducing factor. ARIA was initially characterized as a 42 kDa glycoprotein (Usdin and Fischbach, 1986 ), yet we find that the bacterially expressed, unglycosylated EGF-like domain of HRGI31 is sufficient for ARIA activity. This result is consistent with studies which show that this EGF-like domain is sufficient to activate erbB2, erbB3, and erbB4, putative ARIA receptors belonging to the class I family of receptor tyrosine kinases (Plowman et al., 1993b; Carraway et al., 1994; Kita et al., 1994; Sliwkowski et al., 1994; Tzahar et al., 1994) , and that EGF itself does not possess this property (Plowman et al., 1993a) .
The ability of H RG to activate the ~3500nlacZ transgene in vitro visually underscores the inducing potential of this factor. However, it is unclear why some muscle nuclei cultured from ~3500nlacZ mice fail to express nlacZ even in the presence of rHRGI311~7_2,~. Similar observations have been reported by others using in situ analysis of chicken myotube cultures; these demonstrated preferential activation of the AChR ~ subunit gene in a subset of muscle nuclei (Bursztajn et al., 1989; Fontaine and Changeux, 1989; Harris et al., 1989) . Even in the presence of ARIA, only a fraction of muscle nuclei exhibited induction of this subunit gene (Harris et al., 1989) . Perhaps some molecule that mediates ARIA-induced signaling--either a receptor or corequisite factor--is only variably present on the surface of cultured myotubes. Molecules that are enriched in the synaptic basal lamina of muscle fibers may be candidates, since synaptic basal lamina can direct synapse-specific gene expression in regenerating muscle (Goldman et al., 1991; Brenner et al., 1992; Jo and Burden, 1992) . Although the active factor in synaptic basal lamina is potentially HRG/ARIA itself, other components of lamina may assist in inducing synaptic expression. Despite the insensitivity of some nuclei to the effects of HRG, we find that the population of nuclei capable of expressing the ~ subunit gene in HRG-induced cultures is far larger than the subset of nuclei that actually do express it in innervated muscle.
HRG and Synapse-Specific Regulation of the Subunit Promoter
Previously, we showed that sequences within 280 bp of the subunit gene could direct synapse-specific expression in vivo. In an independent study, Duclert et al. (1993) suggested that sequences within 83 bp of the gene conferred synaptic expression in muscle fibers injected with DNA.
The localization of HRG-responsive sequences to 150 bp of the ~ subunit transcriptional start site indicates that these sequences are the same as those required for synapse-specific expression. Studies examining the potential role of the E box in conferring synapse-specific gene expression have failed to show any involvement (Duclert et al., 1993; Tang et al., 1994) ; analogously, we provide direct evidence that the HRG-dependent activation of the ~ subunit promoter can occur independently of E box sequences. Expression of the ~ subunit gene may be determined by contributions from at least two separate mechanisms of gene activation: activation via the execution of the myogenic differentiation program as well as expression resulting from a HRG-mediated pathway. The apparent magnitude of HRG-inducible gene expression in vitro (or synapse-specific induction in vivo) would thus depend on the relative contribution of both of these two positive influences. In transient transfections of the ~150(mutE)-CAT construct, elimination of the E box results in a reduction of basal levels of expression, but does not as adversely affect HRG-induced stimulation of the reporter gene. As a result, this construct displays an increased response to signaling by HRG.
Postnatal Onset of ~ Subunit Gene Expression
Although there is strong evidence that HRG plays a vital role in synapse-specific gene expression, not all aspects of synapse-specific gene regulation are explained by this inducing factor. HRG mRNA is detectable in the spinal cord as early as embryonic day 9 or 10 during mouse development (Marchionni et al., 1993; Meyer and Birchmeier, 1994 ), yet expression of the ~ subunit gene is minimal until the postnatal period. The delayed onset of ~ subunit expression may result from an insensitivity of the embryonic muscle fiber to the inducing signal. This explanation is unlikely, however, since synapse-specific gene expression can be demonstrated for at least the AChR 7 subunit during fetal development (G. C. C. and J. P. M., unpublished data). Perhaps efficient transcription of the subunit gene requires synaptic induction acting in concert with an additional, as yet unidentified, developmentally regulated factor. The myogenic transcription factor MRF4 may be one possible candidate. MRF4 expression occurs relatively late during fetal development, subsequent to MyoD, myogenin, and myf5 expression (Hinterberger et al., 1991) . In addition, transactivation studies in muscle cell culture suggest that MRF4 can efficiently stimulate expression of the ~ subunit gene (Sunyer and Merlie, 1993) . A synergistic interaction between MRF4 (or some similarly regulated factor) and downstream effectors of a HRG-induced, tyrosine kinase-mediated signaling pathway may account for the postnatal, synapse-specific onset of ~ subunit gene expression. The postnatal decrease of the AChR 7 subunit gene expression that accompanies the rise in ~ expression might lead one to speculate that these processes are controlled by a single regulatory mechanism. The induction of the ~ subunit gene by HRG could occur in concert with a HRG-dependent decrease in expression of the 1, subunit gene. However, our previous findings have shown no such reduction of y subunit mRNA accumulation by native ARIA; this result has been confirmed using rHRG~11~_244 (G. C. C. and J. P. M., unpublished data). Thus, the 7 to ~ transition may reflect multiple regulatory mechanisms, such as the activity-dependent down-regulation of the ~, subunit gene and the postnatal appearance of an ~ subunit regulatory factor, rather than a single coordinated switch.
Induction of Other Genes by HRG/ARIA
A wide variety of proteins are found to be concentrated at the neuromuscular junction (for a list, see Hall and Sanes, 1993) . By in situ hybridization analysis, a small but growing number of genes encoding these proteins have been shown to exhibit synapse-specific or synapse-enriched expression. In addition to the ~ subunit, these include the genes encoding the a, 13, ~', and (5 subunits of the AChR (Fontaine et al., 1988; Goldman and Staple, 1989) . The gene encoding the membrane-associated adhesion molecule N-CAM and the AChR-associated cytoskeletal protein 43K-rapsyn also exhibit mRNA concentration in synaptic muscle nuclei (Moscoso et al., 1995) . Recently, the acetylcholinesterase gene has been shown to be synaptically expressed as well (Jasmin et al., 1993; Michel et al., 1994) , and 7H4, an intriguing muscle-specific, noncoding RNA, shows synaptic enrichment in Northern analysis of diaphragm mRNA (Velleca et al., 1994) . It is tempting to speculate that this heterogeneous population of genes undergoes some degree of coordinate regulation by a nerve-derived factor, namely HRG/ARIA. In support of this hypothesis, the voltage-activated sodium channel, which exhibits aggregation at the base of synaptic junctional folds, has been shown in chicken myotube cultures to increase in abundance in response to ARIA Lupa et al., 1993) . The presence of HRG/ ARIA in the brain and elsewhere suggests a far more global role of this factor in development. Indeed, the HRGs have been shown to restrict neural crest stem cells to a glial fate during early embryogenesis, or to promote astrocyte and oligodendrocyte maturation later in development (Pinkaskramarski et al., 1994; Shah et al., 1994; Vartanian et al., 1994) . Examination of HRG/ARIA-dependent gene expression at the neuromuscular junction may reveal a generalized signaling mechanism that could shed light on inductive events in the central nervous system.
Experimental Procedures Reagents
An 8 kDa peptide corresponding to the EGF-like domain of HRGI31 (residues 177-244)was recombinantiy expressed in E. coli and purified as previously described (Holmes et al., 1992) . EG F was purchased from Boehringer Mannheim. Nerve growth factor and fibroblast growth factor were kindly provided by E. M. Johnson, Jr. and D. M. Orntiz (Washington University School of Medicine), respectively. Recombinant C-terminal agrin was a gift of J. T. Campanelli and R. H. Scheller (Ferns et al., 1993) . The remaining factors and chemicals were obtained from Sigma.
Immunohistochemistry
Sheep antiserum was raised against rHRGI31, a bacterially expressed protein corresponding to amino acids 1-244 of HRGJ31. Affinity purification of antibody was performed by coupling rHRGI31~72~ to an AminoLink Plus column (Pierce). The coupled peptide was incubated in the presence of antiserum for 1 hr in phosphate-buffered saline (PBS). Following washes with PBS, bound antibody was eluted in the presence of 0.1 M glycine (pH 2.75), neutralized in Tris-HCI (pH 9.0), and subsequently dialyzed in PBS. Bovine serum albumin (5 mg/ml) was added as a stabilizer.
Sprague-Dawley rats were purchased from Harlan Sprague Dawley. Rats were anesthetized with methoxyfluorane or ketamine (8.7 mg per 100 g) and xylazine (13 mg per 100 g) injected intraperitoneally. Light microscopic immunohistochemical methods were performed as described (Covault and Sanes, 1986) . In brief, cryostat sections of unfixed muscle were incubated with sheep antibody diluted in a solution of bovine serum albumin in PBS (10 mg/ml) overnight at 4°C or for 3 hr at room temperature, washed, incubated with a fluoresceinconjugated rabbit anti-sheep secondary antibody (Boehringer Mann-helm), and washed again. Sections were mounted and viewed with epifluorescence optics. To identify endptate regions, sections were doubly stained with rhodamine-~-bungarotoxin, which binds to AChRs in the postsynaptic membrane. To define muscle morphology, some sections were stained with crystal violet.
Primary Muscle Cultures
Myogenic cells were prepared essentially as described . Cultures for RNA isolation were prepared from ICR mice (Harlan Spague Dawley) and plated at 5 x 106 cells per 6 cm dish or 14.3 x 106 cells per 10 cm dish. Medium was renewed on day 2 after plating, and again on day 4, with the addition of cytosine arabinonucleoside (araC; 5 I~M). On day 5, cultures were switched to DMEM containing 2% horse serum (differentiation media). In some plates, rHRG~l~77_244 (3 nM) or EGF (3 nM) was added. Cultures were harvested for RNA 48 hr later.
Cells for X-GAL histochemistry or o-nitrophenyl ~-D-galactopyranoside (ONPG) solution assay were obtained from mice bearing the ~3500nlacZ transgene (lines ~29 and s51; Sanes et al., 1991) and the s280nlacZ transgene (Gundersen et al., 1993) . The mice used for the s3500nlacZ muscle cultures were the progeny of a male homozygous for the transgene and a wild-type female, such that each pup in the litter possessed the transgene. Cultures from both adult and newborn mice were analyzed, with equivalent results. For the ~280nlacZ muscle culture, a male heterozygous for the transgene was mated to a wild-type female, resulting in a litter in which approximately 50% of the newborn mice were transgenic. Transgenic cultures were typically plated at 2 x 106 cells per well of a 6 well dish. Cells were fed the following day and switched to differentiation media containing 5 I~M araC on day 3 after plating, rHRG!31~77_244 (3 nM) or other test substances (Table 1) were added 1 day later. Myotubes were typically fed again on day 5 and assayed on day 7, but occasionally they were allowed to remain in culture up to day 10, with periodic media and rHRG~1~77_244 renewal.
Sol 8 Culture and Transfection
Sol 8 cells, a fusion-competent muscle cell line (Mulle et al., 1988) , were maintained in log phase growth by trypsinization and replating in DMEM containing 20% fetal calf serum on gelatin-coated plates. For RNA isolation, these cells were allowed to reach confluence and were switched to differentiation media, rI-IRGI~I ~77-24, (3 nM) was added 24 hr later, and myotube cultures were harvested 2 days afterward.
For transient transfection, Sol 8 cells were plated in 12 well tissue culture dishes at a density of 9 x 104 cells per well. The following day, cells were transfected using the low pH method of calcium phosphate transfection as described by Chen and Okayama (1987) . For each well, 2.2 p.g of a plasmid construct and 0.4 ~g of the ~-galactosidase construct pEVl-lacZ were transfected. Approximately 18 hr after transfection, cells were washed with PBS and switched to differentiation media, rHRGI311~-244 (3 nM) was added directly to the wells the following day. Cultures were refed on day 3 after transfection and harvested on day 5.
RNase Protection Assay
Myotube RNA was isolated by the method of Chomczynski and Sacchi (1987) as modified by Xie and Rothblum (1991) . RNA probe used to detect the AChR ~ transcript has been previously described . Plasmid pBS5PEDlcL, a plasmid containing an 870 bp fragment from the mouse protein synthesis elongation factor Tu (eEFI~, accession #M22432), was used for detection of this mRNA species (Reddy et at., 1988) . Probe synthesis and solution hybridizations using 5-100 p.g of total RNA were performed as described ; for the eEFI(~ probe, hybridization proceeded at 57°C. Following RNase digestion and electrophoresis, gels were dried, exposed to film for visualization, and subjected to phosphorimager quantitation (Molecular Dynamics).
Enzyme Assays
To detect visually the ~-galactosidase product of the nlacZ reporter gene, cells from the transgenic muscle cultures were rinsed twice with PBS and fixed in 2% paraformaldehyde, 0.2% glutaraldehyde in PBS for 5 min. Cells were stained using X-GAL histochemistry procedures as described in Sanes et al. (1991) .
Enzymatic quantitation of 13-galactosidase activity' was performed using ONPG as the substrate. Cells were rinsed with PBS and harvested with a rubber policeman. After low speed centrifugation, the cell pellet was resuspended in 0.25 M Tris-HCI (pH 8.0) and subjected to three rapid freeze-thaw cycles to lyse the cells. Cell lysate was incubated in 0.1 M sodium phosphate (pH 7.0) containing 0.64 mg! ml ONPG, 10 mM MgCI2, and 450 mM ~-mercaptoethanol until reaction was visibly yellow. Absorbance was measured at OD420. To quantitate endogenous levels of ~-galactosidase activity, muscle cultures from nontransgenic mice of the same genetic background (B6CBA F1 hybrids) were treated in an identical fashion.
CAT assays were performed as previously described (Gorman, 1985) but with the following modifications: cells were lysed in 1 x Reporter Lysis Buffer (Promega) for 15 rain and subjected to centrifugation at 12,000 rpm for 10 rain. 13-Galactosidase activity (from the cotransfected pEVl-lacZ plasmid) was used to adjust for variations in transfection efficiency. Owing to a slight nonspecific (1.3-fold) effect of HRG on expression of the pEVl-lacZ plasmid, ~-galactosidase activities from treated and untreated wells transfected with the same construct were averaged to facilitate comparisons within a given construct while normalizing for differences in transfection efficiency among constructs. The CAT assay reaction buffer consisted of 0.25 M Tris-HCI (pH 8.0) containing 200 mg/ml bovine serum albumin. Following separation using thin-layer chromatography, the reaction products were subjected to phosphorimager quantitation.
Plasmid Constructs
Constructs ~280-, ~150-, and s150(mutE)-CAT have been described previously (Sunyer and Merlie, 1993) . pSK-cardiac actin CAT contains a 245 bp EcoRI-Hindlll fragment of promoter sequence from the human cardiac alpha actin gene upstream of the CAT reporter gene in the cloning vector pSKII+ (Miwa and Kedes, 1987) .
pEVl-lacZ, encoding the Rous sarcoma virus promoter fused to the bacterial lacZ gene, was used as a control to normalize for transfection efficiency in the Sol 8 muscle cell line (Pronin and Gautam, 1992) .
